Menu
1 min read · estimated
APPROVED USE
What FDA approved
For adults and children with CD19-positive B-cell precursor ALL in first or second complete remission and measurable residual disease of at least 0.1%.
LAMPGEN ANALYSIS
Why it matters
The action converted the MRD-positive remission indication to traditional approval.
What research teams should watch
Verify the MRD assay and remission number and document the infusion, neurologic and cytokine release monitoring requirements.
PRIMARY RECORDS